Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Genital Herpes01:23

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heterologous COVID-19 vaccine schedule with protein-based prime (NVX-CoV2373) and mRNA boost (BNT162b2) induces strong humoral responses: Results from COV-BOOST trial.

The Journal of infection·2025
Same author

HIV seroconversions and genotypic viral resistance profiles in the PrEP impact trial.

HIV medicine·2025
Same author

Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial.

The Journal of infection·2023
Same author

Corrigendum to "Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial" [J Infect 84(6) (2022) 795-813, 5511].

The Journal of infection·2023
Same author

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial.

The Lancet. Infectious diseases·2022
Same author

Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial.

The Journal of infection·2022
Same journal

Letter to the Editor: 'Life expectancy of UK physicians in the early 21st century: An analysis of 1,000 fellows from the Royal College of Physicians' Munk's Roll'.

Clinical medicine (London, England)·2026
Same journal

Finerenone Exposure and Ischemic Stroke in Patients with Type 2 Diabetes and Chronic Kidney Disease: A Propensity Score-Matched Cohort Study.

Clinical medicine (London, England)·2026
Same journal

Prevalence and predictive factors of chronic kidney disease among individuals with cardiometabolic risk factors: A multicenter cross sectional study, North East Ethiopia.

Clinical medicine (London, England)·2026
Same journal

Authors' response to Dr Lucy Williams' letter to the Editor: 'Life expectancy of UK physicians in the early 21st century: An analysis of 1,000 fellows from the Royal College of Physicians' Munk's Roll'.

Clinical medicine (London, England)·2026
Same journal

Resident doctor workforce wellbeing worldwide: lessons between the United Kingdom and Australia.

Clinical medicine (London, England)·2026
Same journal

Premature ventricular complexes.

Clinical medicine (London, England)·2026
See all related articles

Related Experiment Video

Updated: Jun 19, 2026

The α-test: Rapid Cell-free CD4 Enumeration Using Whole Saliva
11:22

The α-test: Rapid Cell-free CD4 Enumeration Using Whole Saliva

Published on: May 16, 2012

Testing for HIV: concise guidance.

Adrian Palfreeman1, Martin Fisher, Ed Ong

  • 1University Hospitals Leicester. ap@ctu.mrc.ac.uk

Clinical Medicine (London, England)
|November 5, 2009
PubMed
Summary
This summary is machine-generated.

Many people in the UK are unaware of their HIV infection, leading to late diagnosis and health risks. The 2008 UK national guidelines aim to normalize HIV testing for earlier detection and better health outcomes.

More Related Videos

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Related Experiment Videos

Last Updated: Jun 19, 2026

The α-test: Rapid Cell-free CD4 Enumeration Using Whole Saliva
11:22

The α-test: Rapid Cell-free CD4 Enumeration Using Whole Saliva

Published on: May 16, 2012

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Area of Science:

  • Public Health
  • Infectious Diseases
  • Clinical Medicine

Background:

  • HIV is a manageable condition with effective treatments, allowing most individuals to live healthy lives.
  • A significant number of people in the UK remain undiagnosed, posing risks to their health and facilitating virus transmission.
  • Late diagnosis of HIV is a primary driver of HIV-related illness and death in the UK.

Purpose of the Study:

  • To summarize the 2008 UK national guidelines for HIV testing.
  • To provide clinicians with information to facilitate HIV testing within good clinical practice.
  • To promote the normalization of HIV testing in clinical settings.

Main Methods:

  • Review and summarization of the 2008 UK national guidelines for HIV testing.
  • Identification of key recommendations for healthcare professionals.
  • Emphasis on addressing misconceptions that hinder testing.

Main Results:

  • The guidelines offer comprehensive information for performing HIV tests.
  • They aim to equip clinicians with the knowledge for good clinical practice in HIV testing.
  • The recommendations support the 'normalization' of HIV testing, encouraging routine screening.

Conclusions:

  • Normalizing HIV testing is crucial for early detection and improved patient outcomes.
  • Addressing healthcare worker misconceptions is vital to reduce missed or late diagnoses.
  • Adherence to national guidelines can enhance the effectiveness of HIV testing strategies.